DexCom's revenue forecast for FY24 is very close to analyst expectations, which typically suggests a positive outlook on the company's growth and operational efficiency. This alignment with analyst estimates can be seen as a positive signal to investors, potentially leading to increased investor confidence and a positive impact on the stock price in the short term.